List of Tables

Table 1. PCSK9-targeted Therapy Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. PCSK9-targeted Therapy Market Restraints

Table 3. PCSK9-targeted Therapy Market Trends

Table 4. PCSK9-targeted Therapy Industry Policy

Table 5. Global PCSK9-targeted Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global PCSK9-targeted Therapy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global PCSK9-targeted Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global PCSK9-targeted Therapy Mergers & Acquisitions, Expansion Plans

Table 9. Global PCSK9-targeted Therapy Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China PCSK9-targeted Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China PCSK9-targeted Therapy Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of PCSK9-targeted Therapy Upstream (Raw Materials)

Table 14. Global PCSK9-targeted Therapy Typical Customers

Table 15. PCSK9-targeted Therapy Typical Distributors

Table 16. by Type, Global PCSK9-targeted Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global PCSK9-targeted Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global PCSK9-targeted Therapy Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global PCSK9-targeted Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global PCSK9-targeted Therapy Consumption Value Market Share, 2020-2031

Table 23. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position

Table 24. Novo Nordisk Company Profile and Main Business

Table 25. Novo Nordisk PCSK9-targeted Therapy Models, Specifications, and Application

Table 26. Novo Nordisk PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Novo Nordisk Recent Developments

Table 28. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 29. Sanofi Company Profile and Main Business

Table 30. Sanofi PCSK9-targeted Therapy Models, Specifications, and Application

Table 31. Sanofi PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Sanofi Recent Developments

Table 33. Regeneron Company Information, Head Office, Market Area, and Industry Position

Table 34. Regeneron Company Profile and Main Business

Table 35. Regeneron PCSK9-targeted Therapy Models, Specifications, and Application

Table 36. Regeneron PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Regeneron Recent Developments

Table 38. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 39. Amgen Company Profile and Main Business

Table 40. Amgen PCSK9-targeted Therapy Models, Specifications, and Application

Table 41. Amgen PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. Amgen Recent Developments

Table 43. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 44. Novartis Company Profile and Main Business

Table 45. Novartis PCSK9-targeted Therapy Models, Specifications, and Application

Table 46. Novartis PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Novartis Recent Developments

Table 48. Hengrui Pharma Company Information, Head Office, Market Area, and Industry Position

Table 49. Hengrui Pharma Company Profile and Main Business

Table 50. Hengrui Pharma PCSK9-targeted Therapy Models, Specifications, and Application

Table 51. Hengrui Pharma PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. Hengrui Pharma Recent Developments

Table 53. TopAlliance Biosciences Company Information, Head Office, Market Area, and Industry Position

Table 54. TopAlliance Biosciences Company Profile and Main Business

Table 55. TopAlliance Biosciences PCSK9-targeted Therapy Models, Specifications, and Application

Table 56. TopAlliance Biosciences PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. TopAlliance Biosciences Recent Developments

Table 58. Innovent Biologics, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 59. Innovent Biologics, Inc. Company Profile and Main Business

Table 60. Innovent Biologics, Inc. PCSK9-targeted Therapy Models, Specifications, and Application

Table 61. Innovent Biologics, Inc. PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. Innovent Biologics, Inc. Recent Developments

Table 63. Akeso, Inc Company Information, Head Office, Market Area, and Industry Position

Table 64. Akeso, Inc Company Profile and Main Business

Table 65. Akeso, Inc PCSK9-targeted Therapy Models, Specifications, and Application

Table 66. Akeso, Inc PCSK9-targeted Therapy Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. Akeso, Inc Recent Developments

List of Figures

Figure 1. PCSK9-targeted Therapy Picture

Figure 2. Global PCSK9-targeted Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 3. China PCSK9-targeted Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China PCSK9-targeted Therapy Market Share of Global, 2020-2031

Figure 5. Global PCSK9-targeted Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China PCSK9-targeted Therapy Key Participants, Market Share, 2024

Figure 7. PCSK9-targeted Therapy Industry Chain

Figure 8. PCSK9-targeted Therapy Procurement Model

Figure 9. PCSK9-targeted Therapy Sales Model

Figure 10. PCSK9-targeted Therapy Sales Channels, Direct Sales, and Distribution

Figure 11. Subcutaneous Injection

Figure 12. Oral

Figure 13. by Type, Global PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 14. by Type, Global PCSK9-targeted Therapy Consumption Value Market Share, 2020-2031

Figure 15. CVD

Figure 16. Tumor

Figure 17. Acne

Figure 18. Others

Figure 19. by Application, Global PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 20. by Application, Global PCSK9-targeted Therapy Revenue Market Share, 2020-2031

Figure 21. By Region, Global PCSK9-targeted Therapy Consumption Value Market Share, 2020-2031

Figure 22. North America PCSK9-targeted Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 23. By Country, North America PCSK9-targeted Therapy Consumption Value Market Share, 2024

Figure 24. Europe PCSK9-targeted Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 25. By Country, Europe PCSK9-targeted Therapy Consumption Value Market Share, 2024

Figure 26. Asia Pacific PCSK9-targeted Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 27. By Country/Region, Asia Pacific PCSK9-targeted Therapy Consumption Value Market Share, 2024

Figure 28. South America PCSK9-targeted Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 29. By Country, South America PCSK9-targeted Therapy Consumption Value Market Share, 2024

Figure 30. Middle East & Africa PCSK9-targeted Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 31. United States PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 32. by Type, United States PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 33. by Application, United States PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 34. Europe PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 35. by Type, Europe PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 36. by Application, Europe PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 37. China PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 38. by Type, China PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 39. by Application, China PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 40. Japan PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 41. by Type, Japan PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 42. by Application, Japan PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 43. South Korea PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 44. by Type, South Korea PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 45. by Application, South Korea PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 46. Southeast Asia PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 47. by Type, Southeast Asia PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 48. by Application, Southeast Asia PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 49. India PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 50. by Type, India PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 51. by Application, India PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 52. Middle East & Africa PCSK9-targeted Therapy Consumption Value, 2020-2031, US$ Million

Figure 53. by Type, Middle East & Africa PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 54. by Application, Middle East & Africa PCSK9-targeted Therapy Consumption Value Market Share, 2024 VS 2031

Figure 55. Research Methodology

Figure 56. Breakdown of Primary Interviews

Figure 57. Bottom-up Approaches

Figure 58. Top-down Approaches